{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T15:12:29Z","timestamp":1794755549562,"version":"4.9.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.drugalcdep.2020.108416","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T11:45:45Z","timestamp":1606131945000},"page":"108416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011\u20132016"],"prefix":"10.1016","volume":"218","author":[{"given":"Ju Nyeong","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emaan","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-2735","authenticated-orcid":false,"given":"Kathryn","family":"Foti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Zoorob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2020.108416_bib0005","series-title":"The New Jim Crow: Mass Incarceration in the Age of Colorblindness","author":"Alexander","year":"2012"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0010","doi-asserted-by":"crossref","DOI":"10.7326\/M20-1141","article-title":"An epidemic in the midst of a pandemic: opioid use disorder and COVID-19","author":"Alexander","year":"2020","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.drugalcdep.2020.108416_bib0015","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1080\/10826084.2016.1271432","article-title":"Heroin and methamphetamine injection: an emerging drug use pattern","volume":"52","author":"Al-Tayyib","year":"2017","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12954-015-0088-4","article-title":"Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada","volume":"12","author":"Amlani","year":"2015","journal-title":"Harm Reduct. J."},{"issue":"31","key":"10.1016\/j.drugalcdep.2020.108416_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.15585\/mmwr.mm6831a2","article-title":"Notes from the field: unintentional fentanyl overdoses among persons who thought they were snorting cocaine - Fresno, California, January 7, 2019","volume":"68","author":"Armenian","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0030","series-title":"Global Review of Drug Checking Services Operating in 2017, Drug Policy Modelling Program Bulletin","author":"Barratt","year":"2018"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0035","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugpo.2017.05.023","article-title":"Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode island: a mixed methods study","volume":"46","author":"Carroll","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugpo.2017.06.010","article-title":"Fentanyl in the US heroin supply: a rapidly changing risk environment","volume":"46","author":"Ciccarone","year":"2017","journal-title":"Int. J. Drug Policy"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108416_bib0045","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1360-0443.2003.00376.x","article-title":"Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990\u201398","volume":"98","author":"Coffin","year":"2003","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108416_bib0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/YCO.0000000000000069","article-title":"Polysubstance use: diagnostic challenges, patterns of use and health","volume":"27","author":"Connor","year":"2014","journal-title":"Curr. Opin. Psychiatry"},{"issue":"8\u20139","key":"10.1016\/j.drugalcdep.2020.108416_bib0055","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3109\/10826084.2015.1007669","article-title":"War on drugs policing and police brutality","volume":"50","author":"Cooper","year":"2015","journal-title":"Subst. Use Misuse"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108416_bib0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/09595230500286005","article-title":"Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS)","volume":"24","author":"Darke","year":"2005","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"33","key":"10.1016\/j.drugalcdep.2020.108416_bib0070","doi-asserted-by":"crossref","first-page":"837","DOI":"10.15585\/mmwr.mm6533a2","article-title":"Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013\u20132014","volume":"65","author":"Gladden","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"34","key":"10.1016\/j.drugalcdep.2020.108416_bib0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine \u2013 25 states, July\u2013December 2017 to January\u2013June 2018","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0080","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.drugalcdep.2018.10.017","article-title":"Stakeholder perspectives on implementing fentanyl drug checking - results from a multi-site study","volume":"194","author":"Glick","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"10.1016\/j.drugalcdep.2020.108416_bib0085","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jamainternmed.2016.4310","article-title":"Counterfeit medications and fentanyl","volume":"176","author":"Green","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102661","article-title":"An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples","volume":"77","author":"Green","year":"2020","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108416_bib0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12954-017-0179-5","article-title":"An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services","volume":"14","author":"Harper","year":"2017","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0100","first-page":"1","article-title":"Urban-rural differences in drug overdose death rates, by sex, age, and type of drugs involved, 2017","volume":"345","author":"Hedegaard","year":"2019","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0105","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999\u20132018","volume":"356","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.drugalcdep.2020.108416_bib0110","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/add.14878","article-title":"The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States","volume":"115","author":"Hoots","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0115","doi-asserted-by":"crossref","DOI":"10.1093\/epirev\/mxaa011","article-title":"The fourth wave of the overdose epidemic: synthetic opioids and rising stimulant-related harms","author":"Jones","year":"2020","journal-title":"Epidemiol. Rev."},{"issue":"17","key":"10.1016\/j.drugalcdep.2020.108416_bib0120","doi-asserted-by":"crossref","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","article-title":"Drug overdose deaths involving cocaine and psychostimulants with abuse potential - United States, 2003\u20132017","volume":"68","author":"Kariisa","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2018.01.005","article-title":"Expected and actual fentanyl exposure among persons seeking opioid withdrawal management","volume":"86","author":"Kenney","year":"2018","journal-title":"J. Subst. Abuse Treat."},{"issue":"2","key":"10.1016\/j.drugalcdep.2020.108416_bib0130","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","article-title":"Sold as heroin: perceptions and use of an evolving drug in Baltimore, MD","volume":"50","author":"Mars","year":"2018","journal-title":"J. Psychoact. Drugs"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108416_bib0135","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12954-018-0232-z","article-title":"Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency","volume":"15","author":"Mars","year":"2018","journal-title":"Harm Reduct. J."},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108416_bib0140","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.2105\/AJPH.2015.302843","article-title":"Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature","volume":"105","author":"Martins","year":"2015","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0145","series-title":"Table 3: State Counts for Fentanyl and Fentanyl Related Compounds","author":"NFLIS Public Resource Library","year":"2020"},{"issue":"27","key":"10.1016\/j.drugalcdep.2020.108416_bib0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.15585\/mmwr.mm6727a4","article-title":"Notes from the field: overdose deaths with carfentanil and other fentanyl analogs detected - 10 states, July 2016-June 2017","volume":"67","author":"O\u2019Donnell","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"4","key":"10.1016\/j.drugalcdep.2020.108416_bib0155","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/YCO.0000000000000607","article-title":"Drug checking to detect fentanyl and new psychoactive substances","volume":"33","author":"Palamar","year":"2020","journal-title":"Curr. Opin. Psychiatry"},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108416_bib0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12954-018-0240-z","article-title":"Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD","volume":"15","author":"Park","year":"2018","journal-title":"Harm. Reduct. J."},{"issue":"3","key":"10.1016\/j.drugalcdep.2020.108416_bib0165","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1468-0009.12470","article-title":"Situating the continuum of overdose risk in the social determinants of health: a new conceptual framework","volume":"98","author":"Park","year":"2020","journal-title":"Milbank Q."},{"issue":"1","key":"10.1016\/j.drugalcdep.2020.108416_bib0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12954-019-0311-9","article-title":"Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence","volume":"16","author":"Rouhani","year":"2019","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.102642","article-title":"Polysubstance use in rural West Virginia: associations between latent classes of drug use, overdose, and take-home naloxone","volume":"76","author":"Schneider","year":"2020","journal-title":"Int. J. Drug Policy"},{"issue":"11","key":"10.1016\/j.drugalcdep.2020.108416_bib0180","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.2105\/AJPH.91.11.1842","article-title":"Predictors and prevention of nonfatal overdose among street-recruited injection heroin users in the San Francisco Bay Area, 1998\u20131999","volume":"91","author":"Seal","year":"2001","journal-title":"Am. J. Publ. Health"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0185","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2019.03.003","article-title":"Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence","volume":"68","author":"Sherman","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107592","article-title":"A nationally representative analysis of \"twin epidemics\": rising rates of methamphetamine use among persons who use opioids","volume":"204","author":"Strickland","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","article-title":"Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting","volume":"190","author":"Tupper","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0200","series-title":"2018 National Drug Threat Assessment","author":"United States Drug Enforcement Administration","year":"2018"},{"issue":"6","key":"10.1016\/j.drugalcdep.2020.108416_bib0205","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/s41591-020-0898-0","article-title":"An overdose surge will compound the COVID-19 pandemic if urgent action is not taken","volume":"26","author":"Wakeman","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.drugalcdep.2020.108416_bib0210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drugpo.2019.04.010","article-title":"Fentanyl shock: the changing geography of overdose in the United States","volume":"70","author":"Zoorob","year":"2019","journal-title":"Int. J. Drug Policy"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620305810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871620305810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:07:54Z","timestamp":1759828074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871620305810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":42,"alternative-id":["S0376871620305810"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108416","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011\u20132016","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108416","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108416"}}